Gene testing and exenatide response in Chinese type 2 diabetes patients
Part of Hormones & metabolism clinical trials.
This study looks at how certain genes affect the risk of type 2 diabetes and how well the drug exenatide (a GLP-1 receptor agonist) works in Chinese patients. It aims to see if your genetic makeup can predict how you will respond to treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with type 2 diabetes.
- Your body mass index (BMI) is between 20 and 35.
- Your HbA1c (a measure of average blood sugar) is between 7.0% and 12.0%.
- You are between 25 and 70 years old.
- You do not have serious health conditions like recent heart attack, stroke, pancreatitis, kidney or liver disease, or severe stomach problems.
- You have not taken GLP-1 medicines, weight loss drugs, steroids, or drugs that affect digestion in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how certain gene changes affect blood sugar control in type 2 diabetes and also in people who have had pancreas surgery. It compares these groups with healthy volunteers to see how genes influence the risk of diabetes.
This trial looks at how certain cells in the pancreas work in people newly diagnosed with type 2 diabetes. It may help doctors understand the disease better and find new treatment approaches.
This study is looking at whether a specific gene type (rs7903146) affects how the pancreas produces a hormone called GLP-1, which helps control blood sugar. It may help explain why some people are more likely to develop diabetes.
This trial tests an experimental injection (CR059) for type 2 diabetes. It looks at safety and how the body handles different doses. You may qualify if you have had diabetes for 3 months to 5 years and are currently managing it with diet/exercise or certain diabetes pills.
This study looks at how your genes affect your body's response to a diabetes medication called semaglutide. It may help people with slightly high blood sugar (pre-diabetes) understand why some respond better than others.
This early-stage study looks at how genetic factors may change how people respond to a GLP-1 medicine (semaglutide). The goal is to learn who may benefit most and why, so future treatments can be better matched.
Hear when a new Type 2 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.